Day time asthma score Standardised mean difference · Preschool children (<6 years)
1 finding from 1 review
Day time asthma score Mean difference · School‐aged children and adults
1 finding from 1 review
Length of hospitalisation (days) · exacerbations of COPD
1 finding from 1 review
FEV1 · people with bronchiectasis
Erdosteine may leads to higher lung function change in FEV1 (L) at day 15 compared with no treatment (low certainty).
1 finding from 1 review
Rescue‐free days: % change from baseline · patients with chronic asthma
1 finding from 1 review
Intervention not reported
Cough‐free days Percentage of days free of cough · 18 to 80 years of age with bronchiectasis
The intervention may leads to higher cough‐free days Percentage of days free of cough (low certainty).
1 finding from 1 review
Intervention not reported
Length of hospital stay (days) · adults with acute asthma
1 finding from 1 review
Change from baseline mean daily use of β2‐agonists (puffs/day) (duration 24 to 44 weeks) · people with asthma
1 finding from 1 review
Asthma control · Children and adults with persistent asthma.
Intermittent 'as needed' ICS showed no clear difference in proportion of asthma control days over the period (duration 44 to 52… compared with daily ICS (moderate certainty).
1 finding from 1 review
Change from baseline mean daily use of β2‐agonists (puffs/day) (duration 24 to 44 weeks) · Children and adults with persistent asthma.
Intermittent 'as needed' ICS showed no clear difference in change from baseline mean daily use of β2‐agonists (puffs/day)… compared with daily ICS (moderate certainty).
1 finding from 1 review
Asthma relapse1at 20 to 24 days · predominantly adults with acute asthma following emergency department discharge
Any ICS plus oral corticosteroid showed no clear difference in asthma relapse1at 20 to 24 days compared with oral corticosteroid (high certainty).
1 finding from 1 review
Hoarseness at 20 to 24 days · predominantly adults with acute asthma following emergency department discharge
Any ICS plus oral corticosteroid showed no clear difference in hoarseness at 20 to 24 days compared with oral corticosteroid (moderate certainty).
1 finding from 1 review
Asthma relapse1at 16 to 21 days · patients with acute asthma following emergency department discharge
Any ICS showed no clear difference in asthma relapse1at 16 to 21 days compared with oral corticosteroid (moderate certainty).
1 finding from 1 review
Hoarseness at 16 to 21 days · patients with acute asthma following emergency department discharge
Any ICS showed no clear difference in hoarseness at 16 to 21 days compared with oral corticosteroid (low certainty).
1 finding from 1 review
Days lost from work Number of people reporting one or more instances of time off work or school · people with asthma
1 finding from 1 review
Clinical failure Number of children with no significant improvement in cough diary scores at two weeks (average of day 13 to 14) · children with primary (intrinsic) tracheomalacia
Human deoxyribonuclease showed no clear difference in clinical failure Number of children with no significant improvement… compared with placebo (low certainty).
1 finding from 1 review
Cough · children with primary (intrinsic) tracheomalacia
1 finding from 1 review
Intervention not reported
Duration of ventilatory assistance days · individuals with an exacerbation of COPD
1 finding from 1 review
Intervention not reported
Length of hospital stay days · individuals with an exacerbation of COPD
1 finding from 1 review